https://pubmed.ncbi.nlm.nih.gov/39044114/
In recent years, thanks to the advent of new classes of drugs (ARNI and SGLT2-i), the prognosis of patients suffering from heart failure with reduced ejection...
heart failureejection fractionvericiguatreducedhope
https://www.ajmc.com/view/victoria-with-vericiguat-less-cv-death-heart-failure-hospitalization-among-highrisk-patients
The trial showed that patients taking this novel therapy, an oral soluble guanylate cyclase stimulator, were 10% less likely to experience the primary...
death heartvictoriavericiguatlesscv
https://www.ajmc.com/view/merck-gets-priority-review-in-nda-for-vericiguat
The company said FDA has set a date of January 20, 2021, for action under the Prescription Drug User Fee Act.
priority reviewmerckgetsndavericiguat